Besides, blockade of Adrβ3 was shown to accentuate the levels of cytotoxic T lymphocytes and natural killer (NK) cells and attenuate the levels of tumor favoring regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) in melanoma, promoting a favorable immune surveillance (29). Here, ADRB3 is linked to melanoma.